Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors
Year: 2021
Type: article
Source: Neuropsychopharmacology
Institutions: Vanderbilt University, University of California San Diego
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1463480813, Training in Pharmacological Sciences, Metabotropic Glutamate Receptor 7 as a Novel Therapeutic Target for MECP2 Duplication Syndrome, Stratifying Rett syndrome patient populations to evaluate the efficacy of genetic and pharmacological therapeutic interventions, G4462248943, G4558813584, Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt, G6832762225, Sex differences in fast-spiking interneurons promote AUD-related PFC dysfunction: remediation by modulating mGlu1 and mGlu5, Postdoctoral Training in CNS Drug Discovery Research, G8433387623, Functions of Metabotropic Glutamate Receptor Subtypes, Regulation of Signaling by mGluR5, Functions of Metabotropic Glutamate Receptor Subtypes
OpenAlex ID: W3165713600